With an estimated global prevalence of 25%, Non-alcoholic fatty liver disease (NAFLD) is a global public health epidemic that is not receiving enough attention. The first step to taking a comprehensive public health response to NAFLD is to review the relevant policies and guidelines in place. For this reason, EASL International Liver Foundation (EILF) will launch the EILF NAFLD policy review later this month to determine to what extent governments and key stakeholders like medical associations and patient groups are responding to NAFLD and its complications such as diabetes and HCC.

This project is being led by Professors Jeffrey Lazarus (IS Global, University of Barcelona), Professor Quentin Anstee (Newcastle University) and Professor Helena Cortez-Pinto (University Hospital Lisbon). Preliminary results are expected to be announced at the EASL International Liver Congress in April, 2018.

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.


Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.


For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497 gdpr@easl-ilf.org